Actinium Pharmaceuticals (ATNM) Prepaid Assets (2011 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Prepaid Assets of $1.1 million for Q1 2026, little changed year-over-year from $1.1 million in Q1 2025, and down 18.37% quarter-over-quarter from $1.4 million in Q4 2025.
Actinium Pharmaceuticals (ATNM) Prepaid Assets (2011 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Prepaid Assets for 16 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets changed 0.18% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed 0.18% YoY), while the FY2025 annual figure was $1.4 million, down 13.67% from the prior year.
- Prepaid Assets retreated to $1.1 million in Q1 2026 per ATNM's latest filing, from $1.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.3 million in Q2 2023 and bottomed at $65000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $1.5 million across 5 years, with a median of $1.2 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets plunged 92.56% — and 2023, when it surged 1047.69%.
- Actinium Pharmaceuticals' Prepaid Assets stood at $65000.0 in 2022, then soared by 1047.69% to $746000.0 in 2023, then jumped by 114.75% to $1.6 million in 2024, then decreased by 13.67% to $1.4 million in 2025, then fell by 18.37% to $1.1 million in 2026.
- Business Quant data shows ATNM's Prepaid Assets at $1.1 million in Q1 2026, $1.4 million in Q4 2025, and $975000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 975,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 746,000.00 |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 874,000.00 |
| Sep 30, 2021 | 1.18 Mn |